{"DataElement":{"publicId":"5482424","version":"1","preferredName":"BCR/ABL1 Fusion Gene Translocation Breakpoint Present Type","preferredDefinition":"A description of the BCR/ABL1 fusion gene breakpoint that was present.","longName":"5291136v1.0:5482414v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"5291136","version":"1","preferredName":"BCR/ABL1 Fusion Gene Translocation Breakpoint Present","preferredDefinition":"A fusion gene that results from a translocation t(9;22)(q34;q11) that fuses the 5' part of the BCR gene to the 5' side of exon 2 of the ABL1 gene. There are 3 potential products that are formed depending on which BCR exon has the breakpoint. All of the protein products have constitutively active tyrosine kinase activity. This fusion is associated with both chronic myeloid leukemia and acute lymphoblastic leukemia._The point on a chromosome where the normal DNA sequence is juxtaposed with DNA from another chromosome.  Usually expressed as a band number designation (eg. t(9;22) (q34;q11) Philadelphia Chromosome)_Being or existing in a specified place or at the specified time.","longName":"5484975v1.0:2233878v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"5484975","version":"1","preferredName":"BCR/ABL1 Fusion Gene Translocation Breakpoint","preferredDefinition":"A fusion gene that results from a translocation t(9;22)(q34;q11) that fuses the 5' part of the BCR gene to the 5' side of exon 2 of the ABL1 gene. There are 3 potential products that are formed depending on which BCR exon has the breakpoint. All of the protein products have constitutively active tyrosine kinase activity. This fusion is associated with both chronic myeloid leukemia and acute lymphoblastic leukemia.:The point on a chromosome where the normal DNA sequence is juxtaposed with DNA from another chromosome.  Usually expressed as a band number designation (eg. t(9;22) (q34;q11) Philadelphia Chromosome)","longName":"C94600:C13660","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BCR/ABL1 Fusion Gene","conceptCode":"C94600","definition":"A fusion gene that results from a translocation t(9;22)(q34;q11) that fuses the 5' part of the BCR gene to the 5' side of exon 2 of the ABL1 gene. There are 3 potential products that are formed depending on which BCR exon has the breakpoint. All of the protein products have constitutively active tyrosine kinase activity. This fusion is associated with both chronic myeloid leukemia and acute lymphoblastic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Translocation Breakpoint","conceptCode":"C13660","definition":"The point on a chromosome where the normal DNA sequence is juxtaposed with DNA from another chromosome.  Usually expressed as a band number designation (eg. t(9;22) (q34;q11) Philadelphia Chromosome)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3D6C2975-15BC-30A8-E053-F662850ADD77","latestVersionIndicator":"Yes","beginDate":"2016-09-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-09-26","modifiedBy":"ONEDATA","dateModified":"2016-09-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233878","version":"1","preferredName":"Present","preferredDefinition":"Being or existing in a specified place or at the specified time.","longName":"C25626","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Present","conceptCode":"C25626","definition":"Being or existing in a specified place or at the specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F970CDF6-F829-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"ONEDATA","dateModified":"2005-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435027","version":"1","preferredName":"Gene","preferredDefinition":"A functional unit of heredity which occupies a specific position (locus) on a particular chromosome, is capable of reproducing itself exactly at each cell division, and directs the formation of a protein or other product. The gene as a functional unit consists of a discrete segment of a giant DNA molecule containing the purine (adenine and guanine) and pyrimidine (cytosine and thymine) bases in the ordered and correct sequence that encodes a specific functional product (i.e., a protein or RNA molecule).","longName":"C16612","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07431EBC-FB05-25D9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"353EE0ED-AB35-FCAF-E050-BB89AD43034A","latestVersionIndicator":"Yes","beginDate":"2016-06-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-06-14","modifiedBy":"NYCHM","dateModified":"2017-02-02","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5482414","version":"1","preferredName":"BCR/ABL1 Fusion Gene Translocation Breakpoint Type","preferredDefinition":"A fusion gene that results from a translocation t(9;22)(q34;q11) that fuses the 5' part of the BCR gene to the 5' side of exon 2 of the ABL1 gene. There are 3 potential products that are formed depending on which BCR exon has the breakpoint. All of the protein products have constitutively active tyrosine kinase activity. This fusion is associated with both chronic myeloid leukemia and acute lymphoblastic leukemia._The point on a chromosome where the normal DNA sequence is juxtaposed with DNA from another chromosome.  Usually expressed as a band number designation (eg. t(9;22) (q34;q11) Philadelphia Chromosome)_Something distinguishable as an identifiable class based on common qualities.","longName":"5482414v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"p230","valueDescription":"BCR/ABL1 Fusion Gene p230 Translocation Breakpoint","ValueMeaning":{"publicId":"5482701","version":"1","preferredName":"BCR/ABL1 Fusion Gene p230 Translocation Breakpoint","longName":"5482701","preferredDefinition":"A fusion gene that results from a chromosomal translocation t(9;22)(q34;q11) that fuses exon 19 of the BCR gene to the 5' side of exon 2 of the ABL1 gene. This rearrangement is associated with chronic myelogenous leukemia.: The point on a chromosome where the normal DNA sequence is juxtaposed with DNA from another chromosome.  Usually expressed as a band number designation (eg. t(9;22) (q34;q11) Philadelphia Chromosome)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BCR/ABL1 Fusion Gene p230","conceptCode":"C99307","definition":"A fusion gene that results from a chromosomal translocation t(9;22)(q34;q11) that fuses exon 19 of the BCR gene to the 5' side of exon 2 of the ABL1 gene. This rearrangement is associated with chronic myelogenous leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Translocation Breakpoint","conceptCode":"C13660","definition":"The point on a chromosome where the normal DNA sequence is juxtaposed with DNA from another chromosome.  Usually expressed as a band number designation (eg. t(9;22) (q34;q11) Philadelphia Chromosome)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3D334EAA-36D8-590D-E053-F662850AE821","latestVersionIndicator":"Yes","beginDate":"2016-09-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-09-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3D334EAA-36F1-590D-E053-F662850AE821","beginDate":"2016-09-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-09-23","modifiedBy":"ONEDATA","dateModified":"2016-09-23","deletedIndicator":"No"},{"value":"p210","valueDescription":"BCR/ABL1 Fusion Gene p210 Translocation Breakpoint","ValueMeaning":{"publicId":"5482702","version":"1","preferredName":"BCR/ABL1 Fusion Gene p210 Translocation Breakpoint","longName":"5482702","preferredDefinition":"A fusion gene that results from a chromosomal translocation t(9;22)(q34;q11) that fuses the 5' part of the BCR gene between exons 12 and 16 to the 5' side of exon 2 of the ABL1 gene. This rearrangement is associated with chronic myelogenous leukemia, acute lymphoblastic leukemia and acute myeloid leukemia.: The point on a chromosome where the normal DNA sequence is juxtaposed with DNA from another chromosome.  Usually expressed as a band number designation (eg. t(9;22) (q34;q11) Philadelphia Chromosome)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BCR/ABL1 Fusion Gene p210","conceptCode":"C99306","definition":"A fusion gene that results from a chromosomal translocation t(9;22)(q34;q11) that fuses the 5' part of the BCR gene between exons 12 and 16 to the 5' side of exon 2 of the ABL1 gene. This rearrangement is associated with chronic myelogenous leukemia, acute lymphoblastic leukemia and acute myeloid leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Translocation Breakpoint","conceptCode":"C13660","definition":"The point on a chromosome where the normal DNA sequence is juxtaposed with DNA from another chromosome.  Usually expressed as a band number designation (eg. t(9;22) (q34;q11) Philadelphia Chromosome)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3D334EAA-36FE-590D-E053-F662850AE821","latestVersionIndicator":"Yes","beginDate":"2016-09-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-09-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3D334EAA-3717-590D-E053-F662850AE821","beginDate":"2016-09-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-09-23","modifiedBy":"ONEDATA","dateModified":"2016-09-23","deletedIndicator":"No"},{"value":"p190","valueDescription":"BCR/ABL1 Fusion Gene p190 Translocation Breakpoint","ValueMeaning":{"publicId":"5482703","version":"1","preferredName":"BCR/ABL1 Fusion Gene p190 Translocation Breakpoint","longName":"5482703","preferredDefinition":"A fusion gene that results from a chromosomal translocation t(9;22)(q34;q11) that fuses exon 1 of the BCR gene to the 5' side of exon 2 of the ABL1 gene. This rearrangement is associated with acute lymphoblastic leukemia.: The point on a chromosome where the normal DNA sequence is juxtaposed with DNA from another chromosome.  Usually expressed as a band number designation (eg. t(9;22) (q34;q11) Philadelphia Chromosome)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BCR/ABL1 Fusion Gene p190","conceptCode":"C99305","definition":"A fusion gene that results from a chromosomal translocation t(9;22)(q34;q11) that fuses exon 1 of the BCR gene to the 5' side of exon 2 of the ABL1 gene. This rearrangement is associated with acute lymphoblastic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Translocation Breakpoint","conceptCode":"C13660","definition":"The point on a chromosome where the normal DNA sequence is juxtaposed with DNA from another chromosome.  Usually expressed as a band number designation (eg. t(9;22) (q34;q11) Philadelphia Chromosome)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3D334EAA-3724-590D-E053-F662850AE821","latestVersionIndicator":"Yes","beginDate":"2016-09-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-09-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3D334EAA-373D-590D-E053-F662850AE821","beginDate":"2016-09-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-09-23","modifiedBy":"ONEDATA","dateModified":"2016-09-23","deletedIndicator":"No"},{"value":"Other breakpoint","valueDescription":"Other Translocation Breakpoint","ValueMeaning":{"publicId":"5482704","version":"1","preferredName":"Other Translocation Breakpoint","longName":"5482704","preferredDefinition":"Different than the one(s) previously specified or mentioned.: The point on a chromosome where the normal DNA sequence is juxtaposed with DNA from another chromosome.  Usually expressed as a band number designation (eg. t(9;22) (q34;q11) Philadelphia Chromosome)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Translocation Breakpoint","conceptCode":"C13660","definition":"The point on a chromosome where the normal DNA sequence is juxtaposed with DNA from another chromosome.  Usually expressed as a band number designation (eg. t(9;22) (q34;q11) Philadelphia Chromosome)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3D334EAA-374A-590D-E053-F662850AE821","latestVersionIndicator":"Yes","beginDate":"2016-09-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-09-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3D334EAA-3763-590D-E053-F662850AE821","beginDate":"2016-09-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-09-23","modifiedBy":"ONEDATA","dateModified":"2016-09-23","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2565695","version":"1","preferredName":"Unknown","longName":"2565695","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CDAC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-02-26","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-02-26","modifiedBy":"MMADDINENI","dateModified":"2024-02-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"427390EB-1F95-5FAB-E053-F662850A247B","beginDate":"2016-11-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-11-29","modifiedBy":"ONEDATA","dateModified":"2016-11-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"5482705","version":"1","preferredName":"BCR/ABL1 Fusion Gene Translocation Breakpoint Type","preferredDefinition":"A fusion gene that results from a translocation t(9;22)(q34;q11) that fuses the 5' part of the BCR gene to the 5' side of exon 2 of the ABL1 gene. There are 3 potential products that are formed depending on which BCR exon has the breakpoint. All of the protein products have constitutively active tyrosine kinase activity. This fusion is associated with both chronic myeloid leukemia and acute lymphoblastic leukemia.:The point on a chromosome where the normal DNA sequence is juxtaposed with DNA from another chromosome.  Usually expressed as a band number designation (eg. t(9;22) (q34;q11) Philadelphia Chromosome):Something distinguishable as an identifiable class based on common qualities.","longName":"C94600:C13660:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BCR/ABL1 Fusion Gene","conceptCode":"C94600","definition":"A fusion gene that results from a translocation t(9;22)(q34;q11) that fuses the 5' part of the BCR gene to the 5' side of exon 2 of the ABL1 gene. There are 3 potential products that are formed depending on which BCR exon has the breakpoint. All of the protein products have constitutively active tyrosine kinase activity. This fusion is associated with both chronic myeloid leukemia and acute lymphoblastic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Translocation Breakpoint","conceptCode":"C13660","definition":"The point on a chromosome where the normal DNA sequence is juxtaposed with DNA from another chromosome.  Usually expressed as a band number designation (eg. t(9;22) (q34;q11) Philadelphia Chromosome)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3D335B61-8A5F-5F85-E053-F662850AE018","latestVersionIndicator":"Yes","beginDate":"2016-09-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-09-23","modifiedBy":"ONEDATA","dateModified":"2016-09-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3D32F035-E2F5-1D3C-E053-F662850A0BA9","latestVersionIndicator":"Yes","beginDate":"2016-09-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-09-23","modifiedBy":"NYCHM","dateModified":"2017-02-02","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"CMLP_LSDX_BCR_ABL_breakpt_type","type":"NMDP_FN","context":"NHLBI"},{"name":"CMLP_LSLE_BCR_ABL_breakpt_type","type":"NMDP_FN","context":"NHLBI"},{"name":"CMLP_LTHM_BCR_ABL_breakpt_type","type":"NMDP_FN","context":"NHLBI"},{"name":"CMLF_DABR_BCR_ABL_breakpt_type","type":"NMDP_FN","context":"NHLBI"},{"name":"CMLF_PHPI_BCR_ABL_breakpt_type","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What was the BCR/ABL1 fusion","type":"Preferred Question Text","description":"What was the BCR/ABL1 fusion gene breakpoint?","url":null,"context":"NHLBI"},{"name":"Specify BCR / ABL breakpoint","type":"Alternate Question Text","description":"Specify BCR / ABL breakpoint","url":null,"context":"NHLBI"},{"name":"Specify BCR / ABL breakpoint","type":"Application Standard Question Text","description":"Specify BCR / ABL breakpoint","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3D32F035-E3D1-1D3C-E053-F662850A0BA9","latestVersionIndicator":"Yes","beginDate":"2016-09-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-09-23","modifiedBy":"NYCHM","dateModified":"2017-02-02","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}